MedPath

Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer

Phase 2
Terminated
Conditions
Carcinoma, Non-Small-Cell Lung
Registration Number
NCT00210171
Lead Sponsor
Institut Bergonié
Brief Summary

Feasibility of pragmatic concomitant chemo-radiotherapy association with 1 cycle of Induction chemotherapy, weekly chemo-radiotherapy, and consolidation chemotherapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
3
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Objective response
Secondary Outcome Measures
NameTimeMethod
1 and 2 years survival
Toxicity
Time to progression

Trial Locations

Locations (7)

Clinique Tivoli

🇫🇷

Bordeaux, France

Polyclinique Bordeaux Nord

🇫🇷

Bordeaux, France

Centre Hospitalier Universitaire de Bordeaux

🇫🇷

Bordeaux, France

Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest

🇫🇷

Bordeaux, France

Clinique Francheville

🇫🇷

Perigueux, France

Hôpital Robert Boulin

🇫🇷

Libourne, France

Centre de radiothérapie d'Agen

🇫🇷

Agen, France

© Copyright 2025. All Rights Reserved by MedPath